Publications by authors named "David M Ellison"

Claim this Profile
C
CASE (CemiplimAb-rwlc Survivorship and Epidemiology): a study in advanced basal cell carcinoma.
Soo J Park, David M Ellison, Ryan Weight, Jade Homsi, Guilherme Rabinowits

Future Oncol· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
NRG Oncology/NSABP B-47 menstrual history study: impact of adjuvant chemotherapy with and without trastuzumab.
Patricia A Ganz, Reena S Cecchini, Louis Fehrenbacher, Charles E Geyer, Priya Rastogi, David M Ellison

NPJ Breast Cancer· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An open-label, phase II study of the polo-like kinase-1 (Plk-1) inhibitor, BI 2536, in patients with relapsed small cell lung cancer (SCLC).
Mark M Awad, Quincy S-C Chu, Leena Gandhi, Joe J Stephenson, Ramaswamy Govindan, David M Ellison

Lung Cancer· February 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis